A fundamental finding of our study showed a regulatory mechanism of METTL3 on miR-221-3p: METTL3 silencing induced by specific shRNA could reverse the expression pattern of miR-221-3p in BC cells by reducing m6A modification of pri-miR-221-3p. This evidence concerns the gene METTL3 and breast cancer.